M
Masakazu Toi
Researcher at Kyoto University
Publications - 658
Citations - 28522
Masakazu Toi is an academic researcher from Kyoto University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 69, co-authored 578 publications receiving 23200 citations. Previous affiliations of Masakazu Toi include The Breast Cancer Research Foundation & Tokyo Metropolitan Komagome Hospital.
Papers
More filters
Journal ArticleDOI
P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes
S. Johnston,Masakazu Toi,John W. O’Shaughnessy,PS Rastogi,M. Campone,Patrick Neven,C.-S. Huang,Jens Huober,Georgina Garnica Jaliffe,Irfan Cicin,SM Tolaney,Matthew P. Goetz,HS Rugo,Elżbieta Senkus,Laura Testa,Lucia Del Mastro,Chikara Shimizu,Ran Wei,Ashwin Shahir,Mf Munoz,Belen San Antonio,Valerie Andre,Nadia Harbeck +22 more
Journal ArticleDOI
Abstract P5-13-04: Clonal evolution of mammary epithelial cells into breast cancers
Tomomi Nishimura,Nobuyuki Kakiuchi,Kenichi Yoshida,Takaki Sakurai,Tatsuki R. Kataoka,Eiji Kondoh,Yoshitsugu Chigusa,Masahiko Kawai,Morio Sawada,Takuya Inoue,Yasuhide Takeuchi,Hirona Maeda,Satoko Baba,Yusuke Shiozawa,Ryunosuke Saiki,Masahiro Nakagawa,Yasuhito Nannya,Yotaro Ochi,Tomonori Hirano,Yukiko Inagaki-Kawata,Kosuke Aoki,Masahiro Hirata,Eiji Suzuki,Masahiro Takada,M. Kawashima,Kosuke Kawaguchi,Kenichi Chiba,Yuichi Shiraishi,Junko Takita,Satoru Miyano,Masaki Mandai,Kengo Takeuchi,Hironori Haga,Masakazu Toi,Seishi Ogawa +34 more
TL;DR: Nishimura et al. as discussed by the authors analyzed genetic profiles of normal epithelia and proliferative lesions in the cancer-borne breast to illustrate the clonal evolution of cancer from a normal epithelial cell.
Journal ArticleDOI
P292 Cell-free DNA (cfDNA) profiling using Guardant360 in Japanese metastatic breast cancer patients
T. Kawashima,Y. Fujimoto,Wakako Tsuji,Fumiaki Yotsumoto,Youko Komi,Hirofumi Suwa,Tomoe Taji,Ayaka Izumi,Masae Torii,Yasuo Matsutani,Edinei Hideki Suzuki,Mariko Tokiwa,Nobuko Kawaguchi-Sakita,Yuko Mori,Ayane Yamaguchi,Kanako Kawaguchi,M. Takada,Masakazu Toi +17 more
Journal ArticleDOI
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies
Yutaka Yamamoto,Hiroyasu Yamashiro,Andreas Schneeweiss,Volkmar Müller,Oleg Gluz,Peter Klare,Bahriye Aktas,Dank Magdolna,L. Büdi,Bela Piko,László Mangel,Masakazu Toi,Satoshi Morita,Shinji Ohno +13 more
TL;DR: In this article , the authors conducted an international pooled analysis with individual patient data to evaluate the effectiveness of BV + PTX as a first-line treatment for HER2-negative metastatic breast cancer patients under routine practice.
Journal ArticleDOI
Indocyanine green-enhanced thoracoscopic localization of parasternal lymph node: How to do it
TL;DR: This technique rapidly marks the whole chain of enhanced lymph nodes for radical resection, enabling accurate endoscopic resection of small parasternal lymph nodes.